0%
0%
0%
0%
0%
0.94%
−7.05INR
−386.207MINR
1.296BINR
30.538M
About LASA SUPERGENERICS
Sector
CEO
Omkar Pravin Herlekar
Headquarters
Mumbai
Employees
89
Founded
2016
ISIN
INE670X01014
Lasa Supergenerics Ltd. engages in the manufacture of veterinary preparations. It offers veterinary application programming interface products, animal feed ingredients, and reagents for therapeutic use. Its products include Fenbendazole, Toldimphos sodium, Cyromazine, Albendazole, Triclabendazole, Rafoxanide, and Ornidazole. The company was founded on March 11, 2016 and is headquartered in Mumbai, India.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
